Related Experiment Video

Updated: Jan 31, 2026

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
12:28

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies

Published on: March 12, 2022

4.3K

Large Spot Laser for Treatment of Retinopathy of Prematurity

Parijat Chandra, Priti Bhoutekar, Rajvardhan Azad

    Ophthalmic Surgery, Lasers & Imaging Retina
    |December 20, 2018
    PubMed

    Insights

    Large spot laser treatment for retinopathy of prematurity (ROP) significantly reduces procedure time in zones I and II. This method offers a faster, effective alternative for ROP treatment with comparable outcomes and no increased myopia.

    Area of Science:

    • Ophthalmology
    • Pediatric Medicine
    • Laser Surgery

    Background:

    • Retinopathy of prematurity (ROP) is a leading cause of blindness in premature infants.
    • Standard laser photocoagulation for ROP can be time-consuming and painful.
    • Optimizing treatment protocols for ROP is crucial for improving infant outcomes.

    Purpose of the Study:

    • To compare the efficacy and safety of large spot versus standard spot laser photocoagulation for treating retinopathy of prematurity (ROP).
    • To evaluate treatment duration, pain scores, disease regression, and refractive error changes between the two laser spot sizes.

    Main Methods:

    • Eighty eyes of 40 infants with bilateral type 1 ROP were randomized to receive laser photocoagulation using either standard or large spot laser indirect ophthalmoscopy.
    • Treatment time and Premature Infant Pain Profile (PIPP) scores were recorded during the procedure.
    • Disease regression and refractive errors were assessed during follow-up.

    Main Results:

    • Large spot laser significantly reduced treatment duration by 32% in zone I (P = .005) and 63.4% in zone II (P = .0006).
    • Pain scores were comparable between groups, with moderate-to-severe pain observed throughout.
    • No statistically significant difference in the mean change of refractive error (myopia) was found between the groups post-treatment.

    Conclusions:

    • Large spot laser photocoagulation is an effective alternative for ROP treatment, offering a significantly reduced procedure time.
    • The large spot laser provides faster treatment and potentially less overall pain duration with similar disease regression and no increased risk of myopia.
    • This technique can be implemented without specialized training, making it a valuable option for ROP management.
    Abstract

    More Related Videos

    Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents09:28

    Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

    Published on: September 16, 2020

    9.4K
    Application of Optical Coherence Tomography to a Mouse Model of Retinopathy08:22

    Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

    Published on: January 12, 2022

    5.2K

    Related Concept Videos

    Open Angle Glaucoma: Treatment01:27

    Open Angle Glaucoma: Treatment

    In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
    Drugs such as carbonic anhydrase inhibitors, α2- and...
    996
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.8K
    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
    1.2K
    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
    949
    Anticholinesterase Agents: Poisoning and Treatment01:26

    Anticholinesterase Agents: Poisoning and Treatment

    Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
    Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
    1.6K
    Angle Closure Glaucoma: Treatment01:28

    Angle Closure Glaucoma: Treatment

    Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
    1.3K